Morgan Stanley upgraded Fresenius SE to Overweight from Equal Weight with a price target of EUR 39, up from EUR 34. The company has reached a “tipping point on portfolio simplification,” where its Kabi and Helios assets should underpin improved future performance, further supported by self-help initiatives, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FSNUY: